Overview
- 58 inspections across 40 sites are on record.
- 452 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-11-22.
At a glance
Inspections
58
Sites
40
Observations
452
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PCI San Diego, Inc. | 22 Nov 2019 | Human Drugs | View 483 → |
| Huons Co., Ltd. | 18 Oct 2019 | Human Drugs | View 483 → |
| Gilead Sciences, Inc. | 14 May 2019 | Human Drugs | |
| McGuff Pharmaceuticals, Inc. | 26 Mar 2019 | Human Drugs | View 483 → |
| Opto-Pharm Pte Ltd. | 25 Jan 2019 | Human Drugs | View 483 → |
Sites inspected
PCI San Diego, Inc.San Diego, United States1 insp.
Huons Co., Ltd.Jecheon, Korea (the Republic of)1 insp.
Gilead Sciences, Inc.La Verne, United States1 insp.
McGuff Pharmaceuticals, Inc.Santa Ana, United States1 insp.
Opto-Pharm Pte Ltd.Singapore, Singapore1 insp.
Co-investigators
Investigators who share inspections with this person.
Caryn M Mcnab23 shared
Carla J Lundi9 shared
Joey V Quitania5 shared
Uttaniti Limchumroon5 shared
Jamie M Du4 shared
Walden H Lee3 shared
Anastasia M Shields3 shared
Marcus F Yambot3 shared
Virgilio F Pacio3 shared
James R Fleckenstein3 shared
Full investigator report
Get the verbatim findings behind Jennifer M Gogley's 452 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site